Insider Selling: ASP Isotopes (NASDAQ:ASPI) CFO Sells 21,830 Shares of Company Stock

ASP Isotopes Inc. (NASDAQ:ASPI) CFO Heather Kiessling sold 21,830 shares of the business’s stock in a transaction that occurred on Friday, October 16th. The stock was sold at an average price of $2.19, for a total value of $47,807.70. Following the sale, the chief financial officer directly owned 1,504,422 shares in the company, valued at $3,294,684.18. This trade represents a 1.43% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

ASP Isotopes Stock Performance

ASPI opened at $2.17 on Thursday. ASP Isotopes Inc. has a 1-year low of $1.89 and a 1-year high of $11.22. The stock has a market cap of $332.68 million, a P/E ratio of -1.64 and a beta of 3.69. The stock’s 50 day simple moving average is $3.26 and its 200 day simple moving average is $4.68. The company has a debt-to-equity ratio of 0.76, a current ratio of 3.87 and a quick ratio of 3.85.

ASP Isotopes (NASDAQ:ASPI) last issued its quarterly earnings data on Friday, August 14th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.17) by ($0.11). The firm had revenue of $5.12 million for the quarter, compared to analyst estimates of $4.47 million. ASP Isotopes had a negative return on equity of 64.99% and a negative net margin of 427.98%.

Analysts Set New Price Targets

Several research analysts have recently issued reports on ASPI shares. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ASP Isotopes in a research note on Monday, September 21st. Wall Street Zen raised shares of ASP Isotopes from a “strong sell” rating to a “sell” rating in a research note on Saturday, August 22nd. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $13.00.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of the business. The Manufacturers Life Insurance Company raised its position in shares of ASP Isotopes by 8.8% during the 1st quarter. The Manufacturers Life Insurance Company now owns 30,503 shares of the company’s stock worth $135,000 after purchasing an additional 2,470 shares during the last quarter. Sanctuary Advisors LLC raised its holdings in shares of ASP Isotopes by 22.2% in the first quarter. Sanctuary Advisors LLC now owns 24,615 shares of the company’s stock worth $109,000 after acquiring an additional 4,465 shares during the last quarter. Royal Bank of Canada raised its holdings in shares of ASP Isotopes by 18.4% in the first quarter. Royal Bank of Canada now owns 37,954 shares of the company’s stock worth $167,000 after acquiring an additional 5,906 shares during the last quarter. State of Wyoming purchased a new stake in shares of ASP Isotopes in the first quarter valued at $29,000. Finally, Allworth Financial LP purchased a new stake in shares of ASP Isotopes in the second quarter valued at $51,000. 16.80% of the stock is owned by hedge funds and other institutional investors.

ASP Isotopes Company Profile

ASP Isotopes Inc (NASDAQ: ASPI) is a development-stage advanced materials company focused on isotope enrichment. The company is developing proprietary technology intended to separate and enrich isotopes for use in several high-value markets, including nuclear energy, medicine, semiconductors, quantum computing and other industrial applications.

ASP Isotopes has described its platform as being designed to provide more efficient and scalable isotope production than certain conventional enrichment methods.